Stocksigma LogoStocksigma Logo

Shukra Medtech Reports Zero Deviation in Preferential Issue Fund Utilization

Shukra Medtech Limited confirmed zero deviation or variation in utilizing funds raised via 46.43 lakh convertible warrants issued on a preferential basis

Shukra Medtech Reports Zero Deviation in Preferential Issue Fund Utilization

Shukra Pharmaceuticals Ltd · Others (Uncategorized) · 05 Nov 2026, 2:18 am

Shukra Medtech Reports Zero Deviation in Preferential Issue Fund Utilization Shukra Medtech Limited confirmed zero deviation or variation in utilizing funds raised via 46.43 lakh convertible warrants issued on a preferential basis. The company received 75% of the consideration totaling ₹10.46 cr across 14th Jul'26 and 2nd Sep'26. As of the quarter ended 30th Sep'26, the entire ₹10.46 cr proceeds were fully deployed as planned: ₹5.76 cr for working capital and bank guarantee margins, ₹4.23 cr for capex in subsidiary companies, and ₹0.45 cr toward general corporate purposes, with no modifications to original objectives.

Original exchange filing (PDF)

More announcements from Shukra Pharmaceuticals Ltd

All Shukra Pharmaceuticals Ltd announcements